A major wrongful death lawsuit has been filed alleging defects in Abbott Laboratories' (NYSE:ABT) FreeStyle Libre 3 and Libre 3 Plus glucose monitoring systems. The claim links the products to seven ...

Discover the leading players and innovations shaping the global biosensors market with the "Biosensors Companies Quadrant" report by 360 Quadrants. This comprehensive industry analysis evaluates over ...

In a decisive move to fund one of its most significant strategic acquisitions in recent years, Abbott Laboratories has launched a massive $20 billion bond offering. The proceeds are earmarked to ...

Discover the emotional ending of Abbott Elementary season 5 episode 14. Read our full recap explaining how new teacher Dominic confronts Barbara about ADHD medication stigmas, leading to a ...

Management expects 2026 to be its second consecutive year of adjusted EPS growth.

Tests of dozens of baby formulas by Consumer Reports found that nearly half contained potentially dangerous chemicals.

Abbott Laboratories engages in the discovery, development, manufacture, and sale of healthcare products. It operates through the following segments: Established Pharmaceutical Products, Diagnostic ...

Tony Abbott blames record numbers of temporary residents and international students on recent governments. But policy changes ...

Abbott Laboratories (NYSE:ABT) is one of the best 52-week low blue-chip stocks to buy right now. Reuters reported on February 4 that Abbott Laboratories (NYSE:ABT) has logged 860 serious injuries tied ...